Suchergebnisse - "Natarajan, Yamini"

PubPharm (53)

1

Using Natural Language Processing to Automatically Identify Dysplasia in Pathology Reports for Patients With Barrett's Esophagus

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2023

von Nguyen Wenker, T. | Natarajan, Y. | Caskey, K. | +6

2

Clinical Course and Outcomes of Patients with Nonalcoholic Fatty Liver Disease-Related Hepatocellular Cancer (NAFLD-HCC)

enthalten in: Digestive diseases and sciences | 2023

von Chu, J. | Cholankeril, G. | Yu, X. | +5

3

Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes

enthalten in: Digestive diseases and sciences | 2023

von Natarajan, Y. | Patel, P. | Chu, J. | +4

CommentIn: Dig Dis Sci. 2023 Jan;68(1):12-13. - PMID 35816211

4

enthalten in: Hepatology (Baltimore, Md.) | 2022

von Kramer, J. | Natarajan, Y. | Dai, J. | +4

5

Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes

enthalten in: Digestive diseases and sciences | 2022

von Natarajan, Y. | Patel, P. | Chu, J. | +4

6

Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes

enthalten in: Digestive diseases and sciences | 2022

von Natarajan, Y. | Patel, P. | Chu, J. | +4

7

Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes

enthalten in: Digestive diseases and sciences | 2022

von Natarajan, Y. | Patel, P. | Chu, J. | +4

8

Clinical Course and Outcomes of Patients with Nonalcoholic Fatty Liver Disease-Related Hepatocellular Cancer (NAFLD-HCC)

enthalten in: Digestive diseases and sciences | 2022

von Chu, J. | Cholankeril, G. | Yu, X. | +5

9

Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease

enthalten in: Hepatology (Baltimore, Md.) | 2022

von Kramer, J. | Natarajan, Y. | Dai, J. | +4

CommentIn: Hepatology. 2022 Aug;76(2):E48-E49. - PMID 35366349

10

Magnetic Resonance Elastography for the Clinical Risk Assessment of Fibrosis, Cirrhosis, and Portal Hypertension in Patients With NAFLD

enthalten in: Journal of clinical and experimental hepatology | 2022

von Natarajan, Y. | Loomba, R.

1
2
3
4
5
6
Nächster »
[6]